Apparently, the dramatic inhibition of IL-6 secretion with neutralization antibody indicates that Prdx1 may play a critical role in the pathogenesis of I/R related SIRS by promoting inflammation and serve as a novel candidate for the development of therapies against I/R injury. The gene discussed is PRDX1; the disease is systemic inflammatory response syndrome.